Clinical
Explore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.
Learn moreResearch
Aiforia’s research solutions offer fully automated study-centric workflows and pathology image analysis applications that cater to all research areas. Empowered by robust AI capabilities, pathologists and scientists can make discoveries while saving time by automating repetitive tasks – also within the framework of GLP. Aiforia’s solutions can be integrated with any existing laboratory infrastructure to enjoy the full benefits of a digitized workflow.
Learn moreAiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.Learn more >
Learn moreExplore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.
Learn moreAI development tool
Aiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.
Learn moreResources
Explore some of our latest publications showcasing the discoveries enabled by the Aiforia® Platform.
Learn moreAiforia's insights and resources for AI in pathology. View some of our content pieces from the world of AI.
Learn moreStay updated with Aiforia’s recent announcements. Explore our latest news, updates and announcements.
Learn moreCompany
Find out more about shareholder matters, investment discussions, and financial-related information.
Learn moreAiforia's mission is to transform pathology image analysis with AI, enabling better care for each patient. To succeed, we need our trusted partners. Explore Aiforia’s partner network.
Learn moreExperience our AI solutions firsthand. Explore the list of conferences where you can connect with Aiforia’s team live and book a time to discover the future of AI-powered image analysis.
Learn moreOur mission is to transform pathology image analysis with AI, enabling better care for each patient. Find out more about job openings, thesis opportunities, or submitting applications.
Learn moreAiforia Technologies holds information security to the highest standard. We hold several, globally relevant quality and security certifications, so you can be sure your sensitive information is safe.
Learn moreClinical
Clinical Solutions
AI solutions portfolio
Research
AI development tool
Aiforia® Create
Resources
Company
About us
Investors
Partners
Media
Events
Careers
Quality and security
Can Kayatekin, Senior Scientist at Sanofi, runs a group in his lab studying Parkinson’s disease (PD). Their mission is to find targets for therapeutic intervention and to elucidate the disease’s pathophysiology. One of the most time-consuming aspects of his team’s job is cell counting, specifically counting neurons positive for Tyrosine hydroxylase (Th), an enzyme known to be significant in PD.
“We have a lot of counting to do. One of the differences between industry and academia is the number of animals we typically use, like three times as many. So, things do not scale so well. Not only is this task time-consuming, but it is also difficult with traditional, manual methods. It is sometimes hard to recognize or discriminate what we are looking for from background," Can explains.
Aiforia had an existing algorithm for counting Th+ neurons, allowing for this manual task to be automated and delegated to deep learning AI models. Aiforia’s AI model was modified and optimized to fit Can and his team’s work as the AI model was trained with the Sanofi data set. “It worked really well for our purposes, and it was really pain-free on our side,” Can explains as he discusses how this training was done with Aiforia.
“I really liked the collaborative aspect of the training. The Aiforia scientists were trying to get it right as much as we were trying to get it right, which feels good. A lot of times, a company will just give you a product and not be able to tweak it for you. But with Aiforia, it felt more like a collaboration.”
The training was complete when Aiforia’s AI model reached a high degree of accuracy, as Can explains from doing quality control to validate the software's performance: “Aiforia's AI model was about as accurate as any of the human counters were. My expectations were high. And the platform met those.”
In total, 75 slides, with up to 10 sections per slide, were analyzed, and over 150,000 objects were detected and counted by Aiforia. “If you worked 24 hours a day and counted 1 object a second, it would take you a day and a half to count all those objects manually. So, assuming you work your normal 8 hours, you are still looking at counting every second of a whole day for a whole week. Your eyes get tired after looking at these images, and you start to second-guess yourself. The consistency across each of the sections was great with Aiforia; it doesn’t get tired,” Can elaborates on what it would have been like doing this volume of work with traditional methods versus using the Aiforia® Platform.
Can and his team will continue to use Aiforia for other animal studies as more counting needs to be done. “It removes the hurdle of someone sitting down and counting these cells. Counting is not something anybody likes doing. It is a high-annoyance activity. It is good to delegate to a computer if you can.”